Skip Navigation
Print This Page
Share this page: More

Clinical Trials

Currently Enrolling Research Studies in Movement Disorders

Your participation will allow you to have first hand experience with developing new medical treatments, which may be beneficial to many individuals in the future. The current methods that are used to treat neurologic disorders are available because of others who have volunteered their time and energy in the past. Clinical trial information is excerpted from

Parkinson’s DiseaseParkinson Progression Markers Initiative (PPMI) - Prodromal CohortExamine biomarker progression before onset of motor symptomsIndividuals over age 60 without PD but who may have hyposmia (lack of smell), REM behavioral sleep disorder, or LRRK2 genetic mutation
PI: Zoltan Mari, M.D. (NA_00039232)

Arita McCoy, R.N., B.S.N.
(410) 955-2954

Parkinson’s DiseaseNational Parkinson Foundation Patient RegistryDevelop quality care standards for PDAll PD patients and carepartners
PI: Zoltan Mari, M.D. (NA_00036863)
Becky Dunlop, R.N., B.S.N.
(410) 955-8795

Bailey Vernon, M.P.H.
(410) 616-2811
Parkinson’s DiseaseMARK-PDFind biomarkers to improve diagnosis and treatment of people with PDPD patients being treated with PD medications and individuals without PD
PI: Liana Rosenthal, M.D. (NA_00031749)
Nadine Yoritomo, R.N., B.S.N., C.C.R.P.
(410) 616-2822
DystoniaDystonia CoalitionDevelop better understanding of dystonia

Adults 18 and older with primary dystonia
PI: Zoltan Mari, M.D. (NA_00074297)

Becky Dunlop, R.N.
(410) 955-8795
All patientsLongitudinal Study of Parkinson's Disease and Related DisordersMaintain a database of people interested in future studiesAll patients and caregivers
PI: Liana Rosenthal, M.D. (NA_00032761)
Vanessa Johnson, B.S.
(410) 614-1480
Parkinson's DiseaseTranscranial Direct Current StimulationTest the therapeutic relevance of non-invasive brain stimulation for improving motor symptomsDiagnosed PD patients
PI: Reza Shadmehr, Ph.D. (NA_00081426)
Yousef Salimpour, Ph.D.
(410) 614-3424
Movement Disorder with Unkown DiagnosisAVIDDetermine if 18F-AV-133 PET imaging can detect loss or damage of dopamine cellsPeople with movement disorder symptoms but without definite diagnosis
PI: Dean Wong, M.D. (NA_00071306)
Becky Dunlop, R.N.
(410) 955-8795
Parkinson's DiseaseMysticolInvestigate the efficacy of MYOBLOC (Botulinum toxin type B) injection in the treatment of sialorrhea (drooling or excessive salivation)Adults 18 and older with untreated excessive salivation in the last 3 months due to any cause
PI: Zoltan Mari, M.D. (NA_00084484)
Becky Dunlop, R.N.
(410) 955-8795



Movement Disorder Symposium

Our November 8 Symposium was a great success, with the latest in the management of movement disorders from experts at Johns Hopkins Medicine and other health organizations in Maryland. Here's a recap.

PFNCA Annual Symposium:

Dr. Mari discusses past and present Parkinson’s Disease therapies

Sign up for our free e-newsletter

Subscribe to the Parkinson’s Digest free e-newsletter

Email Address:

Out-of-State and International Patients - Find Out More


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.